Bharat Immunological & Biological Corporation Shareholding

Bharat Immunological & Biological Corporation Ltd Shareholding Pattern

The Bharat Immunological & Biological Corporation Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Bharat Immunological & Biological Corporation Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Bharat Immunological & Biological Corporation Ltd (NSE: , BSE: 524663) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Bharat Immunological & Biological Corporation Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Bharat Immunological & Biological Corporation Ltd Shareholding Pattern (Latest)

The latest Bharat Immunological & Biological Corporation Ltd shareholding for Mar 2024 is:

• Promoters: 59.25%
• FII: 0%
• DII: 0%
• Public: 40.75%
• Government: 0%

Promoter holding in Bharat Immunological & Biological Corporation Ltd remains stable, reflecting consistent long-term commitment.

Bharat Immunological & Biological Corporation Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Bharat Immunological & Biological Corporation Ltd.

• Mar 2024: 59.25%
• Sept 2023: 59.25%
• Jun 2023: 59.25%
• Mar 2023: 59.25%
• Dec 2022: 59.25%

Promoter stake remains largely stable, showing consistent ownership structure.

Bharat Immunological & Biological Corporation Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Bharat Immunological & Biological Corporation Ltd.

• Mar 2024: 0%
• Sept 2023: 0%
• Jun 2023: 0%
• Mar 2023: 0%
• Dec 2022: 0%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Bharat Immunological & Biological Corporation Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Mar 2024: 0%
• Sept 2023: 0%
• Jun 2023: 0%
• Mar 2023: 0%
• Dec 2022: 0%

DII holdings remain stable, reflecting steady institutional participation.

Bharat Immunological & Biological Corporation Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Mar 2024: 40.75%
• Sept 2023: 40.75%
• Jun 2023: 40.75%
• Mar 2023: 40.75%
• Dec 2022: 40.75%

Public holding remains stable with consistent retail participation.

Bharat Immunological & Biological Corporation Ltd Government Holding

Government holding in Bharat Immunological & Biological Corporation Ltd currently stands at 0%.

Bharat Immunological & Biological Corporation Ltd operates without significant government ownership.

Bharat Immunological & Biological Corporation Ltd Shareholding Analysis Summary

The Bharat Immunological & Biological Corporation Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Bharat Immunological & Biological Corporation Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Bharat Immunological & Biological Corporation Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.